Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 18/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6166582 | 0.84 | OPRM1 (0.64) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6166153 | 0.81 | CCNA2 (0.47) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6167013 | 0.81 | CCNA2 (0.42) | OPRM1CCNA2CDK2 | |
| SCHEMBL6162652 | 0.81 | CCNA2 (0.45) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6165838 | 0.81 | OPRM1 (0.62) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6164838 | 0.80 | CCNA2 (0.41) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6165095 | 0.80 | ALDH1A1 (0.58) | OPRM1CCNA2CDK2OPRD1OPRK1 | |
| SCHEMBL6164595 | 0.78 | CCNA2 (0.47) | OPRM1CCNA2CDK2HSP90AB1 | |
| SCHEMBL6766480 | 0.77 | OPRM1 (0.57) | OPRM1OPRD1OPRK1HSP90AB1 | |
| SCHEMBL6165217 | 0.77 | OPRM1 (0.53) | OPRM1CCNA2CDK2HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1177185-B1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA ITALIA SPA (IT) | 2005-04-20 | — | — | EP | disclosed |
| US-6716856-B1 | CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY | PHARMACIA & TUBJOHN SPA (IT) | 2004-04-06 | — | — | US | disclosed |
| EP-1177185-A1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000069846-A1 | 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.P.A. (IT) | 2000-11-23 | — | — | WO | disclosed |